Theravance Biopharma, Inc. Area of Real Estate Property
Theravance Biopharma, Inc. (TBPH) had Area of Real Estate Property of 8.00 thousand sqft as of 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Notes › Consolidation and Presentation of Financial Statements
us-gaap:AreaOfRealEstateProperty · last filed 2022-02-28
- 2021-09-30: Area of Real Estate Property 8.00K sqft.
- 2021-07-31: Area of Real Estate Property 8.00K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2021-09-30 | 8.00K sqft 10-Q · filed 2021-11-08 |
| 2021-07-31 | 8.00K sqft 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |